Dates/Times: Friday, June 23 (1-6pm) and Saturday, June 24 (9am-5pm)
Instructor: Richard Gannotta
Registration Deadline: June 12
This course provides a unique opportunity for current and aspiring chaplains and healthcare leaders to better understand the “impact factor” of chaplains (and spiritual care programming more broadly), and how they can be optimized to promote quality of care, access, and cost imperatives. In particular, this course focuses on how chaplains could be, should be, and are/are not fully leveraged by chief executive officers, chief medical/chief nursing officers, and chief human resource officers. The course incorporates conversations with C-Suite-level leaders as well as evidence-based research, popular writing, and personal experiences. Students are provided a unique opportunity to engage in complex and critical conversations with leaders of some of the world’s most prominent hospitals and healthcare systems. Some topics explored are: the role that chaplaincy and spiritual care can play in influencing patient satisfaction; clinical outcomes and clinician well-being; performance and retention; as well as how chaplaincy and spiritual care can be incorporated into organizational strategy and provide a source of competitive advantage.
Richard Gannotta is a recognized health sector leader with service in CEO / president and executive roles in some of the nation’s most prominent academic and public health systems. He is currently serving in key strategic roles advising global med and biotech companies, health systems, and new ventures.
He has held leadership roles as CEO of the University of California Irvine Health System, Senior Vice President of Hospitals at New York’s NYC Health + Hospitals, and roles as President of Chicago’s Northwestern Memorial Hospital, Duke Raleigh Hospital, part of the Duke University Health System, and North Carolina-based Wake Med Health & Hospitals.
Professor Gannotta has a longstanding commitment to academic excellence and is Senior Lecturer of Health Administration at NYU’s Robert F. Wagner Graduate School of Public Service and Co-Director of the MS in Health Law and Strategy, a degree jointly conferred by NYU Wagner and NYU School of Law.
He holds a Doctorate in Healthcare Administration, (MUSC) as well as MBA (Campbell University) and NP/BSN (FIU) degrees. Gannotta’s area of focus revolves around the intersection of biotech innovation and healthcare delivery, its translational and rapid deployment as well as strategic, policy and economic impacts.